RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
9.28
+0.55 (6.30%)
At close: Aug 22, 2025, 4:00 PM
9.11
-0.17 (-1.83%)
After-hours: Aug 22, 2025, 7:46 PM EDT
RxSight Stock Forecast
Stock Price Forecast
The 10 analysts that cover RxSight stock have a consensus rating of "Hold" and an average price target of $11.8, which forecasts a 27.16% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $28.
Price Target: $11.8 (+27.16%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for RxSight stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 1 | 1 |
| Buy | 2 | 1 | 2 | 2 | 1 | 0 |
| Hold | 2 | 4 | 3 | 3 | 8 | 8 |
| Sell | 0 | 1 | 1 | 1 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $16 → $8 | Hold | Maintains | $16 → $8 | -13.79% | Aug 8, 2025 |
| Stifel | Stifel | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | -13.79% | Aug 8, 2025 |
| Needham | Needham | Strong Buy Maintains $22 → $11 | Strong Buy | Maintains | $22 → $11 | +18.53% | Aug 8, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $20 → $9 | Buy → Hold | Downgrades | $20 → $9 | -3.02% | Jul 15, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $24 → $9 | Strong Buy → Hold | Downgrades | $24 → $9 | -3.02% | Jul 10, 2025 |
Financial Forecast
Revenue This Year
128.00M
from 139.93M
Decreased by -8.52%
Revenue Next Year
136.59M
from 128.00M
Increased by 6.71%
EPS This Year
-1.25
from -0.71
EPS Next Year
-1.19
from -1.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 132.7M | 149.6M | 176.8M | |
| Avg | 128.0M | 136.6M | 151.6M | |
| Low | 122.5M | 120.3M | 131.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -5.2% | 16.9% | 29.5% | |
| Avg | -8.5% | 6.7% | 11.0% | |
| Low | -12.5% | -6.1% | -3.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.22 | -0.84 | -0.72 | |
| Avg | -1.25 | -1.19 | -1.09 | |
| Low | -1.31 | -1.41 | -1.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.